Renal clear cell carcinoma (ccRCC) comprises over 75% of all renal tumors and arises in
the epithelial cells of the proximal convoluted tubule. Molecularly ccRCC is characterized by …

In ovarian cancer, there is no current method to accurately predict recurrence after a complete
response to chemotherapy. Here, we develop a machine learning risk score using serum …

Gliomas are currently classified through integration of histology and mutation information,
with new developments in DNA methylation classification. However, discrepancies exist …

Simple Summary We previously reported a gene signature, “Chromophobe-Oncocytoma
Gene Signature” (COGS), to differentiate chromophobe renal cell carcinoma from oncocytoma. …

Chronic low-grade inflammation is involved in the pathogenesis of type-1 diabetes (T1D) and
its complications. In this cross-section study design, we investigated association between …

Publicly available gene expression datasets were analyzed to develop a chromophobe and
oncocytoma related gene signature (COGS) to distinguish chRCC from RO. The datasets …

Simple Summary Molecular classification of cancers has the potential to automate and decrease
errors in cancer classification. We previously showed that transcriptomic classification is …

Multiple cross-sectional and longitudinal studies have shown that serum levels of the
chemokine ligand 2 (CCL-2) are associated with type 1 diabetes (T1D), although the direction of …

Development of complications in type 1 diabetes patients can be reduced by modifying risk
factors. We used a cross-sectional cohort of 1646 patients diagnosed with type 1 diabetes (…

Objective To determine if inflammatory biomarkers can predict the long-term outcome of
platinum therapy in patients with high-grade serous ovarian cancer. Methods Women diagnosed …